Literature DB >> 15483251

Detection and characterization of cytoplasmic hepatitis B virus reverse transcriptase.

Feng Cao1, John E Tavis2,1.   

Abstract

It was recently found that the Duck hepatitis B virus (DHBV) reverse transcriptase is primarily a non-encapsidated cytoplasmic molecule that is rapidly translated and has a very short half-life. Here, a non-encapsidated reverse transcriptase from the human Hepatitis B virus (HBV) was characterized. HBV polymerase accumulated in the cytoplasm in a manner similar to non-encapsidated DHBV polymerase. However, the HBV polymerase accumulated at an apparently lower concentration and had a longer half-life than the DHBV enzyme, and it displayed no evidence of the post-translational modifications observed for DHBV. Unlike the DHBV polymerase, immunofluorescence detection of the HBV polymerase in cells was suppressed by the core protein, and this suppression occurred independently of encapsidation. This implies an interaction between the polymerase and core in addition to encapsidation, but the polymerase and core did not co-immunoprecipitate, so the interaction might not be direct. These data indicate that production of cytoplasmic, non-encapsidated polymerase is conserved among the hepadnaviral genera. Furthermore, conservation of the cytoplasmic form of the polymerase suggests that it might have function(s) in virus replication or pathology beyond copying the viral genome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15483251     DOI: 10.1099/vir.0.80297-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

Review 1.  Hepatitis B virus replication.

Authors:  Juergen Beck; Michael Nassal
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

2.  Inhibition of hepatitis B virus replication by cIAP2 involves accelerating the ubiquitin-proteasome-mediated destruction of polymerase.

Authors:  Zekun Wang; Jinjing Ni; Jianhua Li; Bisheng Shi; Yang Xu; Zhenghong Yuan
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

3.  Sequences in the terminal protein and reverse transcriptase domains of the hepatitis B virus polymerase contribute to RNA binding and encapsidation.

Authors:  F Cao; S Jones; W Li; X Cheng; Y Hu; J Hu; J E Tavis
Journal:  J Viral Hepat       Date:  2014-01-09       Impact factor: 3.728

4.  Purification and enzymatic characterization of the hepatitis B virus ribonuclease H, a new target for antiviral inhibitors.

Authors:  Juan Antonio Villa; Daniel P Pike; Kunjan B Patel; Elena Lomonosova; Gaofeng Lu; Roz Abdulqader; John E Tavis
Journal:  Antiviral Res       Date:  2016-06-17       Impact factor: 5.970

5.  Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways.

Authors:  Yinghui Liu; Jianhua Li; Jieliang Chen; Yaming Li; Weixia Wang; Xiaoting Du; Wuhui Song; Wen Zhang; Li Lin; Zhenghong Yuan
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

6.  Protein-primed terminal transferase activity of hepatitis B virus polymerase.

Authors:  Scott A Jones; Jianming Hu
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

7.  DDX3 DEAD-Box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids.

Authors:  Haifeng Wang; Seahee Kim; Wang-Shick Ryu
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  Four conserved cysteine residues of the hepatitis B virus polymerase are critical for RNA pregenome encapsidation.

Authors:  Seahee Kim; Jehan Lee; Wang-Shick Ryu
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

9.  Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion.

Authors:  Haifeng Wang; Wang-Shick Ryu
Journal:  PLoS Pathog       Date:  2010-07-15       Impact factor: 6.823

10.  Hepatitis B Virus Polymerase Localizes to the Mitochondria, and Its Terminal Protein Domain Contains the Mitochondrial Targeting Signal.

Authors:  Nuruddin Unchwaniwala; Nathan M Sherer; Daniel D Loeb
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.